Last updated: 08/07/2025 12:10:07

A study assessing the safety, efficacy, and impact of GlaxoSmithKline Biologicals' RTS, S/AS01E malaria vaccine in young children across sub-Saharan AfricaEPI-MAL-003

GSK study ID
115056
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Recruitment complete
Recruitment complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: A prospective study to evaluate the safety, effectiveness and impact of the RTS, S/AS01E vaccine in young children in sub-Saharan Africa
Trial description: The RTS, S/AS01E vaccine was developed to protect children in sub-Saharan Africa from malaria as part of routine immunization programs. This study aims to check the vaccine's safety after it has been introduced. Along with safety, researchers will also assess how well the vaccine works and its overall impact on children's health.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

Incidence rates of adverse events of special interest (AESI)

Timeframe: During the entire study period (From Day 0 up to Month 62)

Incidence rates of aetiology-confirmed meningitis

Timeframe: During the entire study period (From Day 0 up to Month 62)

Secondary outcomes:

Incidence rate of probable meningitis (final classification)

Timeframe: During the entire study period (From Day 0 up to Month 62)

Incidence rates of clinically suspected meningitis (final classification)

Timeframe: During the entire study period (From Day 0 up to Month 62)

Number of meningitis cases identified at site level (first line laboratory)

Timeframe: During the entire study period (From Day 0 up to Month 62)

Incidence rates of cerebral malaria (diagnosed by Rapid Diagnostic Test [RDT] and/or microscopy)

Timeframe: During the entire study period (From Day 0 up to Month 62)

Incidence rates of malaria episodes diagnosed by RDT and/or microscopy

Timeframe: During the entire study period (From Day 0 up to Month 62)

Incidence rates of anaemia cases at hospital entry among hospitalised children

Timeframe: During the entire study period (From Day 0 up to Month 62)

Incidence rates of hospitalisation cases

Timeframe: During the entire study period (From Day 0 up to month 62)

Number of deaths

Timeframe: During the entire study period (From Day 0 up to month 62)

Interventions:
  • Procedure/surgery: Whole blood sample
  • Enrollment:
    77969
    Primary completion date:
    2025-11-08
    Observational study model:
    Cohort
    Time perspective:
    Prospective
    Clinical publications:
    Not applicable
    Medical condition
    Malaria
    Product
    SB257049
    Collaborators
    Not applicable
    Study date(s)
    March 2019 to August 2025
    Type
    Observational
    Phase
    4

    Participation criteria

    Sex
    Female & Male
    Age
    Not applicable - 5 Years
    Accepts healthy volunteers
    Yes
    • Inclusion Criteria
    • All study participants must satisfy ALL the following criteria at study entry:

    Trial location(s)

    Location
    Status
    Contact us
    Contact us
    Location
    GSK Investigational Site
    Navrongo, Ghana, N/A
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mangochi, Malawi, N/A
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kintampo, Ghana, N/A
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chikwawa, Malawi, N/A
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kisumu, Kenya, 4 0100
    Status
    Study Complete

    Study documents

    No study documents available.

    Results overview

    No study documents available

    Recruitment status
    Recruitment complete
    Actual primary completion date
    Not applicable
    Actual study completion date
    Not applicable

    Plain language summaries

    Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

    Additional information about the trial

    Not applicable
    Participate in clinical trial
    Access to clinical trial data by researchers
    Visit website